US5795286A - Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation - Google Patents

Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation Download PDF

Info

Publication number
US5795286A
US5795286A US08/698,577 US69857796A US5795286A US 5795286 A US5795286 A US 5795286A US 69857796 A US69857796 A US 69857796A US 5795286 A US5795286 A US 5795286A
Authority
US
United States
Prior art keywords
radioisotope
sheet
biodegradable
mesh
adhesions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/698,577
Inventor
Robert E. Fischell
David R. Fischell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gaylord Container Corp
Cathco Inc
Original Assignee
Cathco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cathco Inc filed Critical Cathco Inc
Priority to US08/698,577 priority Critical patent/US5795286A/en
Assigned to CATHCO, INC. reassignment CATHCO, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FISCHELL, DAVID R., FISCHELL, ROBERT E.
Application granted granted Critical
Publication of US5795286A publication Critical patent/US5795286A/en
Assigned to GAYLORD CONTAINER CORPORATION reassignment GAYLORD CONTAINER CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: S&G PACKAGING COMPANY, L.L.C.
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1028—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy using radiation sources applied onto the body
    • A61N5/1029—Radioactive dressings

Definitions

  • This invention is in the field of materials used to prevent post-operative scar tissue proliferation which can result in surgical adhesions.
  • This invention is a radioisotope impregnated material sheet or mesh designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really scar tissue formation.
  • This mesh or gauze into which the isotope is placed may be either a permanent implant or it may be biodegradable.
  • an existing product such as the Johnson & Johnson SURGICELTM absorbable hemostat gauze-like sheet with a beta emitting radioisotope such as phosphorous-32 with has a relatively short effective range of approximately 4 mm, the biodegradable mesh would act as a barrier to cell proliferation and hence be a deterrent to the formation of adhesions.
  • Another object of this invention is to have a biodegradable radioisotope sheet of material or mesh.
  • Still another object of this invention is to have the radioisotope be a pure beta emitter.
  • Another object of this invention is to have the beta emitter be phosphorous-32.
  • Still another object is to have the activity of phosphorous-32 on the sheet of material or mesh be between 0.2 and 2 ⁇ Ci per square centimeter.
  • Yet another object is to have the activity of phosphorous-32 be between 2 and 20 ⁇ Ci per square centimeter.
  • FIG. 1 is a plan view of a sheet of radioisotope impregnated mesh.
  • FIG. 2 is an enlargement of the cross section of a single strand of the mesh where the radioisotope is embedded within the strand.
  • FIG. 3 is an enlargement of the cross section of a single strand of the mesh where the radioisotope is coated onto the strand.
  • FIG. 4 shows a cross section of the radioisotope impregnated or coated mesh placed between two layers of tissue of the human body.
  • FIG. 1 shows an absorbable hemostat mesh sheet 10 with mesh strands 12 and open spaces 11.
  • the sheet 10 is designed to be placed post-operatively between internal body tissues.
  • the mesh strands 12 can be made from oxidized regenerated cellulose or other biodegradable materials with the radioisotope either embedded within the strands or coated onto the outer surfaces of the strands.
  • FIG. 2 is an enlargement of a cross section of a single strand 12 of the mesh 10 in which the radioisotope 14 is embedded within the strand 12.
  • FIG. 3 is an enlargement of the cross section of a single strand 16 of the mesh where the radioisotope 17 is coated onto the exterior surface of the strand.
  • FIG. 4 shows the radioisotope impregnated mesh 10 placed between two adjacent tissues 20 and 21 of a human body.
  • the mesh 10 would be inserted during a surgical procedure typically just before closing of the surgical incision.
  • the biodegradable mesh 10 dissolves or is absorbed into the tissue 20 or 21, because the radioisotope is not encapsulated within a non-soluble structure, the radioisotope embedded into or coated onto the mesh 10 will become dispersed into the tissue 20 or 21.
  • the radioisotopes that may be used are primarily beta emitters such as phosphorous-32, phosphorous-33, or calcium 45. If phosphorus-32 is used, the activity range should be between 0.2 and 20 ⁇ Ci/cm 2 . If the mesh is coated, an insoluble suspension of P-32 such as that used to treat ovarian cancer would be appropriate either by itself or mixed with another biodegradable material.
  • a radioisotope can be made to be part of any sheet of material that is or is not biodegradable, as long as the sheet of material is biocompatible. In any case the radiation from the radioisotope that is included within at least part of the sheet of material will decrease cellular proliferation and therefore decrease the formation of scar tissue and adhesions.

Abstract

This invention is a radioisotope impregnated material sheet or mesh designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really scar tissue formation. This mesh or gauze into which the isotope is placed may be either a permanent implant or it may be biodegradable. By impregnating an existing product such as the Johnson & Johnson SURGICEL™ absorbable hemostat gauze-like sheet with a beta emitting radioisotope such as phosphorous-32 with has a relatively short effective range of approximately 4 mm, the biodegradable mesh would act as a barrier to cell proliferation and hence be a deterrent to the formation of adhesions.

Description

FIELD OF USE
This invention is in the field of materials used to prevent post-operative scar tissue proliferation which can result in surgical adhesions.
BACKGROUND OF THE INVENTION
Post-operative adhesions are a major problem following abdominal and other surgical procedures. These adhesions are caused by the unwanted proliferation of scar tissue between internal tissues and structures of the human body. Several companies have developed sheets of biodegradable mesh which can be placed between these structures to reduce the tissue growth. None are entirely effective as the cells typically grow through the mesh. U.S. Pat. No. 5,059,166 (which is included herein by reference) describes the use of a beta emitting radioisotope to reduce the proliferation of tissue through the wires of a wire mesh tube (a stent) placed into an artery.
SUMMARY OF THE INVENTION
This invention is a radioisotope impregnated material sheet or mesh designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really scar tissue formation. This mesh or gauze into which the isotope is placed may be either a permanent implant or it may be biodegradable. By impregnating an existing product such as the Johnson & Johnson SURGICEL™ absorbable hemostat gauze-like sheet with a beta emitting radioisotope such as phosphorous-32 with has a relatively short effective range of approximately 4 mm, the biodegradable mesh would act as a barrier to cell proliferation and hence be a deterrent to the formation of adhesions.
Thus it is an object of this invention to have a sheet of material that can be placed between internal body tissues, the material being impregnated or coated with a radioisotope to reduce the scar tissue proliferation between adjacent layers of the human tissue.
Another object of this invention is to have a biodegradable radioisotope sheet of material or mesh.
Still another object of this invention is to have the radioisotope be a pure beta emitter.
Another object of this invention is to have the beta emitter be phosphorous-32.
Still another object is to have the activity of phosphorous-32 on the sheet of material or mesh be between 0.2 and 2 μCi per square centimeter.
Yet another object is to have the activity of phosphorous-32 be between 2 and 20 μCi per square centimeter.
These and other objects and advantages of this invention will become obvious to a person of ordinary skill in this art upon reading of the detailed description of this invention including associated drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a plan view of a sheet of radioisotope impregnated mesh.
FIG. 2 is an enlargement of the cross section of a single strand of the mesh where the radioisotope is embedded within the strand.
FIG. 3 is an enlargement of the cross section of a single strand of the mesh where the radioisotope is coated onto the strand.
FIG. 4 shows a cross section of the radioisotope impregnated or coated mesh placed between two layers of tissue of the human body.
DETAILED DESCRIPTION OF THE DRAWINGS
FIG. 1 shows an absorbable hemostat mesh sheet 10 with mesh strands 12 and open spaces 11. The sheet 10 is designed to be placed post-operatively between internal body tissues. The mesh strands 12 can be made from oxidized regenerated cellulose or other biodegradable materials with the radioisotope either embedded within the strands or coated onto the outer surfaces of the strands.
FIG. 2 is an enlargement of a cross section of a single strand 12 of the mesh 10 in which the radioisotope 14 is embedded within the strand 12.
FIG. 3 is an enlargement of the cross section of a single strand 16 of the mesh where the radioisotope 17 is coated onto the exterior surface of the strand.
FIG. 4 shows the radioisotope impregnated mesh 10 placed between two adjacent tissues 20 and 21 of a human body. The mesh 10 would be inserted during a surgical procedure typically just before closing of the surgical incision. When the biodegradable mesh 10 dissolves or is absorbed into the tissue 20 or 21, because the radioisotope is not encapsulated within a non-soluble structure, the radioisotope embedded into or coated onto the mesh 10 will become dispersed into the tissue 20 or 21.
The radioisotopes that may be used are primarily beta emitters such as phosphorous-32, phosphorous-33, or calcium 45. If phosphorus-32 is used, the activity range should be between 0.2 and 20 μCi/cm2. If the mesh is coated, an insoluble suspension of P-32 such as that used to treat ovarian cancer would be appropriate either by itself or mixed with another biodegradable material.
Although a mesh has been discussed herein, more generally, a radioisotope can be made to be part of any sheet of material that is or is not biodegradable, as long as the sheet of material is biocompatible. In any case the radiation from the radioisotope that is included within at least part of the sheet of material will decrease cellular proliferation and therefore decrease the formation of scar tissue and adhesions.
Various other modifications, adaptations, and alternative designs are of course possible in light of the above teachings. Therefore, it should be understood at this time that within the scope of the appended claims the invention may be practiced otherwise than as specifically described herein.

Claims (13)

What is claimed is:
1. A biodegradable sheet of material adapted for implantation between tissues of a human body, at least part of said sheet of material including a radioisotope, said radioisotope being placed within a soluble structure which is said biodegradable sheet of material so that the radioisotope becomes dispersed into the human body.
2. The apparatus of claim 1 wherein the radioisotope is embedded within the sheet of material.
3. The apparatus of claim 1 wherein the radioisotope is coated onto the sheet of material.
4. The apparatus of claim 1 wherein the radioisotope is predominantly a beta emitter.
5. The apparatus of claim 4 wherein the beta emitter is phosphorous-32.
6. The apparatus of claim 1 wherein the sheet of material is in the form of a mesh.
7. The apparatus of claim 1 wherein the radioisotope is embedded within the biodegradable material.
8. The apparatus of claim 1 wherein the radioisotope is coated onto the biodegradable material.
9. The apparatus of claim 1 wherein the radioisotope is predominantly a beta emitter.
10. A method for the prevention of scar tissue formation and adhesions associated with a surgical procedure, the method comprising the following steps:
a) place a radioisotope that is free from encapsulation into a non-soluble structure into a biodegradable sheet of material: and
b) place the sheet of material containing the radioisotope into a human body between tissues that are separated by a surgical incision.
11. The method of claim 10 including the step of closing the surgical incision after the sheet of material is placed between the separated tissues.
12. A biodegradable material adapted for implantation between tissues of a human body, at least part of said biodegradable material including a radioisotope, said biodegradable material and said radioisotope each being adapted to be absorbed into the human body.
13. The apparatus of claim 12 wherein the beta emitter is phosphorous-32.
US08/698,577 1996-08-15 1996-08-15 Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation Expired - Fee Related US5795286A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US08/698,577 US5795286A (en) 1996-08-15 1996-08-15 Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/698,577 US5795286A (en) 1996-08-15 1996-08-15 Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation

Publications (1)

Publication Number Publication Date
US5795286A true US5795286A (en) 1998-08-18

Family

ID=24805836

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/698,577 Expired - Fee Related US5795286A (en) 1996-08-15 1996-08-15 Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation

Country Status (1)

Country Link
US (1) US5795286A (en)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051299A2 (en) * 1998-03-11 1999-10-14 Bionucleonics, Inc. Radioactive composition for fabrication of implanted device
US6019718A (en) 1997-05-30 2000-02-01 Scimed Life Systems, Inc. Apparatus for intravascular radioactive treatment
US6048299A (en) * 1997-11-07 2000-04-11 Radiance Medical Systems, Inc. Radiation delivery catheter
US6059812A (en) * 1997-03-21 2000-05-09 Schneider (Usa) Inc. Self-expanding medical device for centering radioactive treatment sources in body vessels
US6059713A (en) 1997-03-06 2000-05-09 Scimed Life Systems, Inc. Catheter system having tubular radiation source with movable guide wire
US6071227A (en) * 1993-07-01 2000-06-06 Schneider (Europe) A.G. Medical appliances for the treatment of blood vessels by means of ionizing radiation
US6099454A (en) 1996-02-29 2000-08-08 Scimed Life Systems, Inc. Perfusion balloon and radioactive wire delivery system
US6110097A (en) 1997-03-06 2000-08-29 Scimed Life Systems, Inc. Perfusion balloon catheter with radioactive source
US6132360A (en) * 1998-05-22 2000-10-17 Halpern; Alan A. Magnetic stretching of magnetized neurons for spinal cord or peripheral nerve repair and regeneration
US6146322A (en) 1995-12-05 2000-11-14 Schneider (Europe) Ag Irradiating filament and method of making same
US6149574A (en) * 1997-12-19 2000-11-21 Radiance Medical Systems, Inc. Dual catheter radiation delivery system
US6176821B1 (en) 1997-01-31 2001-01-23 Radiance Medical Systems, Inc. Radiation delivery balloon catheter
US6187037B1 (en) * 1998-03-11 2001-02-13 Stanley Satz Metal stent containing radioactivatable isotope and method of making same
US6203485B1 (en) 1999-10-07 2001-03-20 Scimed Life Systems, Inc. Low attenuation guide wire for intravascular radiation delivery
WO2001024841A1 (en) * 1999-10-01 2001-04-12 Johnson & Johnson Medical Limited Compositions for the treatment of wound contracture
US6231494B1 (en) 1994-06-10 2001-05-15 Schneider (Europe) A.G. Medical device with radiation source
US6234951B1 (en) 1996-02-29 2001-05-22 Scimed Life Systems, Inc. Intravascular radiation delivery system
WO2001036047A1 (en) * 1999-11-18 2001-05-25 Schrayer Howard L Device for the inhibition of cellular proliferation
US6258019B1 (en) 1997-09-26 2001-07-10 Scimed Life Systems, Inc. Catheter for intraluminal treatment of a vessel segment with ionizing radiation
US6261320B1 (en) 1996-11-21 2001-07-17 Radiance Medical Systems, Inc. Radioactive vascular liner
US6264596B1 (en) 1997-11-03 2001-07-24 Meadox Medicals, Inc. In-situ radioactive medical device
US6287249B1 (en) 1998-02-19 2001-09-11 Radiance Medical Systems, Inc. Thin film radiation source
US6302865B1 (en) 2000-03-13 2001-10-16 Scimed Life Systems, Inc. Intravascular guidewire with perfusion lumen
US6352501B1 (en) 1999-09-23 2002-03-05 Scimed Life Systems, Inc. Adjustable radiation source
WO2002036054A1 (en) * 2000-11-06 2002-05-10 Afmedica, Inc. Surgically implanted devices having reduced scar tissue
US6398709B1 (en) 1999-10-19 2002-06-04 Scimed Life Systems, Inc. Elongated member for intravascular delivery of radiation
US6398708B1 (en) 1996-02-29 2002-06-04 Scimed Life Systems, Inc. Perfusion balloon and radioactive wire delivery system
US6413203B1 (en) 1998-09-16 2002-07-02 Scimed Life Systems, Inc. Method and apparatus for positioning radioactive fluids within a body lumen
US6416457B1 (en) 2000-03-09 2002-07-09 Scimed Life Systems, Inc. System and method for intravascular ionizing tandem radiation therapy
WO2002056747A2 (en) * 2000-11-13 2002-07-25 Isotech, L.L.C. Radioactive medical devices for inhibiting a hyperplastic response
US6458069B1 (en) 1998-02-19 2002-10-01 Endology, Inc. Multi layer radiation delivery balloon
US6491619B1 (en) 1997-01-31 2002-12-10 Endologix, Inc Radiation delivery catheters and dosimetry methods
WO2002100479A2 (en) * 2001-06-12 2002-12-19 Isotech, Llc Radioactive medical devices and methods of making radioactive medical devices
US20030152609A1 (en) * 2000-11-06 2003-08-14 Fischell Robert E. Devices and methods for reducing scar tissue formation
US6616629B1 (en) 1994-06-24 2003-09-09 Schneider (Europe) A.G. Medical appliance with centering balloon
US20030233136A1 (en) * 2001-06-13 2003-12-18 Williams John I. Brachytherapy device and method
US6676590B1 (en) 1997-03-06 2004-01-13 Scimed Life Systems, Inc. Catheter system having tubular radiation source
US20040008999A1 (en) * 2002-06-12 2004-01-15 Ayako Iino Image forming apparatus
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
US20040091421A1 (en) * 2001-02-22 2004-05-13 Roger Aston Devices and methods for the treatment of cancer
WO2004052238A2 (en) * 2002-12-10 2004-06-24 University Of Florida Phototherapy bandage
US20040197409A1 (en) * 2001-01-16 2004-10-07 Vascular Therapies, Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US20080085855A1 (en) * 2002-09-26 2008-04-10 Angiotech International Ag Perivascular wraps
US20100228074A1 (en) * 2006-08-25 2010-09-09 C.R. Bard, Inc. Therapeutic and Directionally Dosed Implants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292630A1 (en) * 1984-11-21 1988-11-30 Bruce S. Dr. Horowitz Radiation therapy delivery systems
US5059166A (en) * 1989-12-11 1991-10-22 Medical Innovative Technologies R & D Limited Partnership Intra-arterial stent with the capability to inhibit intimal hyperplasia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292630A1 (en) * 1984-11-21 1988-11-30 Bruce S. Dr. Horowitz Radiation therapy delivery systems
US5059166A (en) * 1989-12-11 1991-10-22 Medical Innovative Technologies R & D Limited Partnership Intra-arterial stent with the capability to inhibit intimal hyperplasia

Cited By (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514191B1 (en) 1993-07-01 2003-02-04 Schneider (Europe) A.G. Medical appliances for the treatment of blood vessels by means of ionizing radiation
US6071227A (en) * 1993-07-01 2000-06-06 Schneider (Europe) A.G. Medical appliances for the treatment of blood vessels by means of ionizing radiation
US6074338A (en) 1993-07-01 2000-06-13 Schneider (Europe) A.G. Medical appliances for the treatment of blood vessels by means of ionizing radiation
US6582352B2 (en) 1994-06-10 2003-06-24 Schneider (Europe) A.G. Medical appliance for treatment by ionizing radiation
US6231494B1 (en) 1994-06-10 2001-05-15 Schneider (Europe) A.G. Medical device with radiation source
US6616629B1 (en) 1994-06-24 2003-09-09 Schneider (Europe) A.G. Medical appliance with centering balloon
US6146322A (en) 1995-12-05 2000-11-14 Schneider (Europe) Ag Irradiating filament and method of making same
US6234951B1 (en) 1996-02-29 2001-05-22 Scimed Life Systems, Inc. Intravascular radiation delivery system
US6599230B2 (en) 1996-02-29 2003-07-29 Scimed Life Systems, Inc. Intravascular radiation delivery system
US6099454A (en) 1996-02-29 2000-08-08 Scimed Life Systems, Inc. Perfusion balloon and radioactive wire delivery system
US6398708B1 (en) 1996-02-29 2002-06-04 Scimed Life Systems, Inc. Perfusion balloon and radioactive wire delivery system
US6261320B1 (en) 1996-11-21 2001-07-17 Radiance Medical Systems, Inc. Radioactive vascular liner
US6699170B1 (en) 1997-01-31 2004-03-02 Endologix, Inc. Radiation delivery balloon catheter
US6491619B1 (en) 1997-01-31 2002-12-10 Endologix, Inc Radiation delivery catheters and dosimetry methods
US6176821B1 (en) 1997-01-31 2001-01-23 Radiance Medical Systems, Inc. Radiation delivery balloon catheter
US6676590B1 (en) 1997-03-06 2004-01-13 Scimed Life Systems, Inc. Catheter system having tubular radiation source
US6059713A (en) 1997-03-06 2000-05-09 Scimed Life Systems, Inc. Catheter system having tubular radiation source with movable guide wire
US6110097A (en) 1997-03-06 2000-08-29 Scimed Life Systems, Inc. Perfusion balloon catheter with radioactive source
US6117065A (en) 1997-03-06 2000-09-12 Scimed Life Systems, Inc. Perfusion balloon catheter with radioactive source
US6059812A (en) * 1997-03-21 2000-05-09 Schneider (Usa) Inc. Self-expanding medical device for centering radioactive treatment sources in body vessels
US6267775B1 (en) 1997-03-21 2001-07-31 Schneider (Usa) Inc. Self-expanding medical device for centering radioactive treatment sources in body vessels
US6422989B1 (en) 1997-05-30 2002-07-23 Scimed Life Systems, Inc. Method for intravascular radioactive treatment
US6019718A (en) 1997-05-30 2000-02-01 Scimed Life Systems, Inc. Apparatus for intravascular radioactive treatment
US6258019B1 (en) 1997-09-26 2001-07-10 Scimed Life Systems, Inc. Catheter for intraluminal treatment of a vessel segment with ionizing radiation
US6264596B1 (en) 1997-11-03 2001-07-24 Meadox Medicals, Inc. In-situ radioactive medical device
US6048299A (en) * 1997-11-07 2000-04-11 Radiance Medical Systems, Inc. Radiation delivery catheter
US6149574A (en) * 1997-12-19 2000-11-21 Radiance Medical Systems, Inc. Dual catheter radiation delivery system
US6685618B2 (en) 1998-02-19 2004-02-03 Endologix, Inc. Method for delivering radiation to an intraluminal site in the body
US6458069B1 (en) 1998-02-19 2002-10-01 Endology, Inc. Multi layer radiation delivery balloon
US6287249B1 (en) 1998-02-19 2001-09-11 Radiance Medical Systems, Inc. Thin film radiation source
WO1999051299A2 (en) * 1998-03-11 1999-10-14 Bionucleonics, Inc. Radioactive composition for fabrication of implanted device
WO1999051299A3 (en) * 1998-03-11 2002-11-14 Bionucleonics Inc Radioactive composition for fabrication of implanted device
US6187037B1 (en) * 1998-03-11 2001-02-13 Stanley Satz Metal stent containing radioactivatable isotope and method of making same
US6132360A (en) * 1998-05-22 2000-10-17 Halpern; Alan A. Magnetic stretching of magnetized neurons for spinal cord or peripheral nerve repair and regeneration
US6413203B1 (en) 1998-09-16 2002-07-02 Scimed Life Systems, Inc. Method and apparatus for positioning radioactive fluids within a body lumen
US6352501B1 (en) 1999-09-23 2002-03-05 Scimed Life Systems, Inc. Adjustable radiation source
WO2001024841A1 (en) * 1999-10-01 2001-04-12 Johnson & Johnson Medical Limited Compositions for the treatment of wound contracture
US6203485B1 (en) 1999-10-07 2001-03-20 Scimed Life Systems, Inc. Low attenuation guide wire for intravascular radiation delivery
US6398709B1 (en) 1999-10-19 2002-06-04 Scimed Life Systems, Inc. Elongated member for intravascular delivery of radiation
WO2001036047A1 (en) * 1999-11-18 2001-05-25 Schrayer Howard L Device for the inhibition of cellular proliferation
US6416457B1 (en) 2000-03-09 2002-07-09 Scimed Life Systems, Inc. System and method for intravascular ionizing tandem radiation therapy
US6302865B1 (en) 2000-03-13 2001-10-16 Scimed Life Systems, Inc. Intravascular guidewire with perfusion lumen
US20040241211A9 (en) * 2000-11-06 2004-12-02 Fischell Robert E. Devices and methods for reducing scar tissue formation
US20040071756A1 (en) * 2000-11-06 2004-04-15 Afmedica, Inc. Devices and methods for reducing scar tissue formation
US6534693B2 (en) * 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
WO2002036054A1 (en) * 2000-11-06 2002-05-10 Afmedica, Inc. Surgically implanted devices having reduced scar tissue
US20030152609A1 (en) * 2000-11-06 2003-08-14 Fischell Robert E. Devices and methods for reducing scar tissue formation
US20040006296A1 (en) * 2000-11-06 2004-01-08 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US20070110796A1 (en) * 2000-11-06 2007-05-17 Angiotech Pharmaceuticals, Inc. Devices and methods for reducing scar tissue formation
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
US20120065222A1 (en) * 2000-11-06 2012-03-15 Fischell Robert Devices and methods for reducing scar tissue formation
US6612976B2 (en) 2000-11-13 2003-09-02 Isotech, L.L.C. Radioactive medical devices and methods of making radioactive medical devices
US6616592B1 (en) 2000-11-13 2003-09-09 Isotech, L.L.C. Radioactive medical devices for inhibiting a hyperplastic response and method of making radioactive medical devices
WO2002056747A3 (en) * 2000-11-13 2003-02-27 Isotech L L C Radioactive medical devices for inhibiting a hyperplastic response
WO2002056747A2 (en) * 2000-11-13 2002-07-25 Isotech, L.L.C. Radioactive medical devices for inhibiting a hyperplastic response
US10272073B2 (en) 2001-01-16 2019-04-30 Vascular Therapies, Inc. Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US8858982B2 (en) 2001-01-16 2014-10-14 Vascular Therapies, Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US20040197409A1 (en) * 2001-01-16 2004-10-07 Vascular Therapies, Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US7807191B2 (en) * 2001-01-16 2010-10-05 Vascular Therapies, Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US20040091421A1 (en) * 2001-02-22 2004-05-13 Roger Aston Devices and methods for the treatment of cancer
US8647603B2 (en) 2001-02-22 2014-02-11 Enigma Therapeutics Limited Devices and methods for the treatment of cancer
US8097236B2 (en) 2001-02-22 2012-01-17 Psimedica Limited Devices and methods for the treatment of cancer
WO2002100479A2 (en) * 2001-06-12 2002-12-19 Isotech, Llc Radioactive medical devices and methods of making radioactive medical devices
WO2002100479A3 (en) * 2001-06-12 2003-09-18 Isotech Llc Radioactive medical devices and methods of making radioactive medical devices
US7182726B2 (en) * 2001-06-13 2007-02-27 Williams John I Brachytherapy device and method
US20030233136A1 (en) * 2001-06-13 2003-12-18 Williams John I. Brachytherapy device and method
US7304201B2 (en) 2002-06-12 2007-12-04 University Of Florida Research Foundation, Inc. Phototherapy bandage
US20080058689A1 (en) * 2002-06-12 2008-03-06 University Of Florida Research Foundation, Inc. Phototherapy bandage
US20040166146A1 (en) * 2002-06-12 2004-08-26 University Of Florida Phototherapy bandage
US20040008999A1 (en) * 2002-06-12 2004-01-15 Ayako Iino Image forming apparatus
US20080085855A1 (en) * 2002-09-26 2008-04-10 Angiotech International Ag Perivascular wraps
WO2004052238A3 (en) * 2002-12-10 2004-10-14 Univ Florida Phototherapy bandage
WO2004052238A2 (en) * 2002-12-10 2004-06-24 University Of Florida Phototherapy bandage
US20100228074A1 (en) * 2006-08-25 2010-09-09 C.R. Bard, Inc. Therapeutic and Directionally Dosed Implants

Similar Documents

Publication Publication Date Title
US5795286A (en) Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation
US6575887B1 (en) Devices for the inhibition or suppression of cellular proliferation in tubular body structures
US3688317A (en) Vascular prosthetic
US20210023278A1 (en) Porous bioabsorbable implant
EP0528998B1 (en) Periodontal tissue regeneration barrier
US4955909A (en) Textured silicone implant prosthesis
US6849089B2 (en) Implant with proliferation-inhibiting substance
US4712553A (en) Sutures having a porous surface
EP0528971B1 (en) Surgical implant and method incorporating chemotherapeutic agents
CA2158638A1 (en) A Composition and a Method for Tissue Augmentation
MX9700443A (en) Hard tissue stimulating agent.
MXPA03003906A (en) Surgically implanted devices having reduced scar tissue.
CA2450956A1 (en) Surgical implant
GB2194151A (en) Support for biomedical implant device
CA2304296A1 (en) Pelvic floor reconstruction
WO1996003091A1 (en) Surgical product and its use
CA2471890A1 (en) Implantable prosthesis
JP2003513749A (en) Device for protecting nerves after surgical procedure
JPH10503099A (en) Prosthesis for abdominal wall
FI83729B (en) SURGICAL IMPLANTS.
EP0117072A1 (en) Vascular prosthesis
Eyssen et al. Reconstruction of the breast using polyurethane-coated prostheses
US4713073A (en) Plastic implant
WO1999046594A3 (en) C-myc coding region determinant-binding protein (crd-bp)
HU9700161D0 (en) Desintegrant

Legal Events

Date Code Title Description
AS Assignment

Owner name: CATHCO, INC., MARYLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FISCHELL, ROBERT E.;FISCHELL, DAVID R.;REEL/FRAME:008870/0447

Effective date: 19971129

AS Assignment

Owner name: GAYLORD CONTAINER CORPORATION, ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:S&G PACKAGING COMPANY, L.L.C.;REEL/FRAME:012188/0802

Effective date: 19991220

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20020818